Regular ArticleThe interaction between p53 and papillomaviruses☆
References (88)
- et al.
Characterisation of events during the late stages of HPV 16 infection in vivo using high affinity synthetic Fabs to E4
Virology
(1997) - et al.
p53-from inductive signal to cellular effect
Curr Opin Genet Dev
(1997) p53, the cellular gatekeeper for growth and division
Cell
(1997)- et al.
p53 in signalling checkpoint arrest or apoptosis
Curr Opin Genet Dev
(1996) - et al.
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Cell
(1990) - et al.
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Cell
(1993) - et al.
A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential
Virology
(1997) - et al.
Degradation of p53 can be targeted by HPV sequences distinct from those required for p53 binding and transactivation
Cell
(1991) - et al.
Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6
Virology
(1996) - et al.
Codon 72 p olymorphism of p53 and its association with cervical cancer
Lancet
(1999)
p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large-T antigen
Virology
(1996)
p53 protein exhibits 3′-to-5′ exonuclease activity
Cell
(1996)
Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviuses of human origin for their ability to transform 3Y1 cells
Virology
(1993)
Prognostic significance of polymerase chain reaction detected human papillomavirus of tumours and lymph nodes in surgically treated stage IB cervical cancer
Gynecol Oncol
(1992)
E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box
J Biol Chem
(1998)
Viruses in human cancer
Science
(1991)
Papillomaviruses,
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Nature
(1985)
Proc Natl Acad Sci USA
(1998)
Human Papillomavirus E6 and E7: proteins which deregulate the cell cycle
BioEssays
(1995)
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
Genes Dev
(1997)
Inactivation of the cdk inhibitor p27KIP1by the human papillomavirus type 16 E7 oncoprotein
Oncogene
(1996)
Analysis of a protein-binding domain of p53
Mol Cell Biol
(1993)
Several hydrophobic aminoacids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B-55kD protein
Genes Dev
(1994)
The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells
Oncogene
(1998)
Hepatitis B virus X protein and p53 tumour suppressor interactions in the modulation of apoptosis
Proc Natl Acad Sci USA
(1997)
Interactions of human papillomavirus type 16 E6 oncoprotein with wild type and mutant human p53
J Virol
(1992)
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 and 18
EMBO J
(1991)
ocalisation of the E 6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins
Mol Cell Biol
(1993)
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase
Proc Natl Acad Sci USA
(1995)
The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate
Eur J Biochem
(1998)
Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells
Oncogene
(1997)
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
Proc Natl Acad Sci USA
(1998)
Inhibition of bak induced apoptosis by HPV-18 E6
Oncogene
(1998)
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
Nature
(1998)
High risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation
J Virol
(1996)
Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells
Oncogene
(1994)
Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6
J Gen Virol
(1998)
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription
EMBO J
(1992)
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
J Virol
(1994)
Cited by (0)
- ☆
Unspecified
Copyright © 2000 Academic Press. All rights reserved.